Trump health official: Controversial drug pricing move is 'top priority'

A top Trump administration health official on Thursday indicated that the administration is pushing forward with a controversial proposal to lower drug prices, despite opposition from some fellow Republicans.

Centers for Medicare and Medicaid Services Administrator Seema Verma told reporters that the proposal to lower certain drug prices in Medicare by tying them to lower prices in other countries, known as the International Price Index, is a “top priority.”